Clinical Informatics News Contributed Commentary In January 2017, there were 4,003 pharmaceutical companies with nearly 15,000 drugs in the pipeline. Yet only 1 in 5 drugs actually make it to market. Technology inherently aims to streamline processes, eliminate manual effort and create efficiencies, but is technology still doing this for clinical research?
Novartis says it will scale up the use of Apple ResearchKit in clinical trials, as part of its efforts to bring about digital transformation.
The post Novartis and Apple to scale up clinical trial collaboration appeared first on Pharmaphorum. https://pharmaphorum.com/news/researchkit-novartis-apple-scale-clinical-trial-collaboration/
The rise of wearable technology for clinical trials
The post The rise of wearable technology for clinical trials: insights from Novartis appeared first on Pharmaphorum. https://pharmaphorum.com/partner-content/the-rise-of-wearable-technology-for-clinical-trials-insights-from-novartis/
NewsThe Propeller platform has been used by patients and physicians in over 55 commercial programs across the United States.Contributed Author: Propeller HealthTopics: Biotech https://www.dddmag.com/news/2017/08/propeller-health-expands-digital-health-r-d-partnership-gsk
Takeda is increasing its R&D investment in oncology with a collaboration with Texas biotech Molecular Templates. The Japanese
The post Takeda begins new R&D link-up with Molecular Templates appeared first on Pharmaphorum. https://pharmaphorum.com/news/takeda-begins-new-rd-link-molecular-templates/
Adimab, LLC is transferring its proprietary antibody discovery and optimization platform to Lilly research sites in San Diego and New York. http://www.outsourcing-pharma.com/Preclinical-Research/Eli-Lilly-licenses-Adimab-antibody-discovery-and-optimization-tech
Six years after Pfizer’s landmark REMOTE trial, Parexel and Sanofi are teaming up in a pilot study to revisit the idea of using wearables in clinical trials. http://www.fiercebiotech.com/cro/parexel-sanofi-explore-use-wearables-clinical-trial
Biopharmas are always on the hunt for ever-elusive innovations, but some are better at allocating investment than others. Here are five charts showing how the industry spends on R&D. http://www.biopharmadive.com/news/industry-pulse-biopharma-research-development-spending/443506/
San Diego’s Scientist.com set out in 2006 to disrupt part of the pharmaceutical business by providing an Amazon-like approach to the business of hiring contract research organizations (CROs). The company, which operates a network of online markets for outsourcing biomedical research services and supplies, has raised $24 million in a new round of venture funding. […] http://www.xconomy.com/san-diego/2017/05/15/scientist-com-raises-24m-for-pharma-markets-that-outsource-rd/
Sanofi and Artificial Intelligence (AI)-driven Exscientia have announced a €250m ($271.9m) drug target research collaboration and licence option agreement. http://www.outsourcing-pharma.com/Preclinical-Research/Sanofi-s-250m-AI-driven-R-D-collaboration-for-metabolic-disease